1,8-Dihydroxyanthracène-9(10H)-one ≥99%, poudre jaune
Marques : MP BiomedicalsTotal Evaluation: 0
Moyenne des Notes : 0.0 sur 5
|
Attention
|
Dithranol (1, 8 - dihydroxy-9-anthrone) is also known as anthralin. It is a vital topical antipsoriatic drugs. Dithranol, an athracene derivative, is a free radical generating mitochondrial poison that induces apoptosis in keratinocytes.
Dithranol, a potential anti-psoriasis medication, may be used to study its safety, efficacy, metabolism and pharmacological profile. Dithranol may be used to study is physicochemical properties, as a reference compound and to develop effective drug delivery vehicles. Dithranol may be used as a matrix for matrix assisted laser desorption/ionization imaging on a Fourier transform ion cyclotron resonance mass spectrometer.
Dithranol, an athracene derivative, is a free radical generating mitochondrial poison that induces apoptosis in keratinocytes. Dithranol is being studied as a potential anti-psoriasis medication.
Soluble in chlororform (20 mg/ml - clear, bright yellow solution) and in fixed oilds; slightly soluble in ethanol (95%) and in ether; practically insoluble in water.
Formule:
C₁₄H₁₀O₃ Point d'ébullition: 400 °C (1013 hPa) Point de fusion: 193,5 - 195 °C Densité: 1,433 g/cm³ (20 °C) Température de stockage: Température ambiante |
Numéro MDL:
MFCD00053409 Numéro CAS: 1143-38-0 EINECS: 214-538-0 Indice Merck: 12,00723 |
Résultats des tests de spécification
Identity Test | Passes |
Purity | ≥99% |
FTIR | Conforms to Standard |
Melting Point | 175 - 182°C |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...